Orforglipron is actually a daily tablet that only targets GLP-1. It’s a “small molecule,” which implies it may endure digestion and be absorbed by your body, when more substantial peptide medicines like tirzepatide could be broken down during the tummy and have to be injected.This lesser measurement allows orforglipron to survive digestion an